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SUMMARY
This study determined the genetic background of virulence and resistance genes of MRSA
ST398 in Austria. From 2004 up to 2008 a total of 41 human isolates of MRSA ST398 were
investigated for virulence and resistance gene patterns using DNA microarray chip analysis.
Highly similar virulence gene proﬁles were found in 29 (70.7%) of the isolates but genes encoding
Panton–Valentine leukocidin, enterotoxins, or toxic shock syndrome toxin were not detected.
Genes conferring resistance to tetracycline and erythromycin-lincosamide were common as all but
one of the isolates exhibited tetM and/or tetK, which are involved in tetracycline resistance, and
12 (29.9%) were positive for ermC, conferring resistance to erythromycin/lincosamide. SplitsTree
analysis showed that 40 isolates were closely related. Changes in virulence and resistance gene
patterns were minimal over the observed time period.
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In recent years the emergence of methicillin-resistant
Staphylococcus aureus (MRSA) sequence type 398
(ST398), known as live-stock-associated MRSA (LA-
MRSA) has attracted particular attention. This is due
to its association with pigs and pig farming and its
ability to colonize or infect people, such as farmers,
who work in close contact with these animals [1, 2].
Less frequently MRSA ST398 has been found in a
variety of other farm animals, such as horses, poultry,
or cattle and from foods of animal origin. Although
inter-human transmission has been described, the in-
cidence of MRSA ST398, especially in hospitals, ap-
pears to be much lower than for other MRSA
genotypes [1].
MRSA ST398 usually lacks the virulence determi-
nants that are typically found in hospital-acquired
MRSA or community-acquired MRSA. The majority
of analysedMRSA ST398 isolates carried haemolysin-
encoding genes, only a small number of isolates car-
ried the bicomponent leukotoxin Panton–Valentine
(lukPV) genes or staphylococcal enterotoxins (SE; se
genes). Genes for other toxins, i.e. exfoliative toxins
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(ET), leukocidins or toxic shock syndrome toxins
(TSST-1) have not as yet been reported in MRSA
ST398 isolates [3, 4].
Phenotypically, MRSA ST398 is resistant to
oxacillin and all b-lactam antibiotics. Resistance to
tetracycline is also very common due to its frequent
use in pig and cattle farming [5]. Resistance to other
antibiotics, especially erythromycin, clindamycin,
aminoglycosides or trimethoprim/sulfamethoxazole
has been reported; however, multi-resistance to o3
antimicrobial groups is uncommon [1, 3].
In Austria intensive pig farming with about 1.2
million pigs is concentrated in two regions (north and
south-east) which are served by two microbiological
laboratories and these account for practically all hu-
man MRSA ST398 isolates reported in Austria [2, 6].
The aim of this study was to determine whether the
virulence and antimicrobial resistance gene proﬁles of
MRSA ST398 in human isolates in Austria diﬀer be-
tween the two regions or whether animal trading
throughout the country resulted in the spread of
identical MRSA ST398 clones.
From January 2004 to December 2008, 41 MRSA
ST398 isolates were identiﬁed from a total of about
1900 MRSA human primary isolates, from routine
samples at two microbiological laboratories in
Austria (27 from Linz, 14 from Graz). As published
previously, contact with animals (predominantly pigs
and/or cows, and horses or hens only) was docu-
mented in 32 patients. Clinical manifestations ranged
from solely colonization to purulent infections in-
cluding a case of complicated osteomyelitis. The
number of MRSA ST398 detected per year increased
steadily from one isolate in 2004 to 16 in 2008 [2, 6].
All MRSA ST398 isolates were retested for
susceptibility to the following antimicrobial agents :
oxacillin, tetracycline, erythromycin, clindamycin,
gentamicin, trimethoprim/sulfamethoxazole, quinu-
pristin/dalfopristin, fusidic acid, daptomycin,
rifampicin, linezolid, vancomycin, and chloramph-
enicol by E-tests (bioMe´rieux, France) according to
the guidelines of the Clinical and Laboratory Stan-
dards Institute (CLSI) [7]. Isolates were also further
characterized by spa typing, multilocus sequence
typing (MLST) and SCCmec typing as described
previously [6].
Identibac MRSA bacterial genotyping system
(Identibac, UK; StaphyType, Alere Technologies
GmbH, Germany) was used to characterize the iso-
lates, according to the manufacturer’s instructions
and recently published recommendations [8]. This
DNA microarray comprises 334 target sequences,
which correspond to 171 distinct genes and their
allelic variants, including S. aureus speciﬁc genes,
accessory gene regulator (agr) alleles and genes
coding for virulence factors (toxins, enterotoxins,
haemolysins, proteases, bioﬁlm formation molecules).
Hybridization patterns were analysed using Splits
Tree4 software (www.splitstree.org), designed to
compute unrooted phylogenetic networks from mol-
ecular sequence data. Gene proﬁles were converted to
‘sequence-like ’ strings of information, deﬁning pres-
ent genes as ‘A’ (positive), absent genes as ‘T’
(negative) and spots with ambiguous signal intensities
as missing [9].
Spa typing of the 41MRSA ST398 isolates assigned
36 to spa type t011, two each to t034 and t2346, and
one to t1451. Types t011 and t034 were found in both
the north and south-east of Austria whereas t2346
was conﬁned to the north; the t1451 isolate originated
in the south-east. All, but one, of the isolates were of
SCCmec type V and the outlier (t034) was of SCCmec
type IV. All isolates were of agr type I.
As expected resistance to oxacillin was universal
but 13 (31.7%) isolates exhibited a multidrug resist-
ance phenotype with resistance too3 classes of anti-
microbial agents. All but one isolate were resistant
to tetracycline and 13 expressed constitutive eryth-
romycin-clindamycin resistance (cMLSB); three iso-
lates were resistant to gentamicin and one to
chloramphenicol. The single tetracycline-susceptible
isolate was of type t034 and originated from northern
Austria.
None of the isolates exhibited resistance to tri-
methoprim/sulfamethoxazole, quinupristin/dalfopris-
tin, fusidic acid, daptomycin, rifampicin, linezolid,
and vancomycin.
Determination of the resistance gene proﬁles using
the DNA microarray demonstrated concordant re-
sults with susceptibility data. All isolates were positive
for the mecA gene and 40 harboured the ampicillin-
penicillin resistance gene blaZ and the tetracycline
resistance gene tetM ; 28 isolates carried the tetK
gene. Regarding genes involved in resistance to eryth-
romycin-clindamycin (MLSB), ermC was detected in
13 isolates, which was in agreement with phenotypic
resistance patterns but ermA and ermB were not
identiﬁed in any of the isolates and none harboured
other macrolide resistance genesmsrA,mefA,mpbBM
and the clindamycin resistance gene linA. Three iso-
lates carried the streptogramin resistance gene vga,
two isolates the aminoglycoside resistance genes
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aacA-aphD and one was positive for ﬂexA (conferring
resistance to chloramphenicol). A single isolate car-
ried the mecA gene only and no further resistance
genes.
All 41 isolates were negative for genes encoding
PVL (lukS-PVL, lukF-PVL), enterotoxins (ent genes),
and the toxic shock syndrome toxin (tst-1). By con-
trast all isolates were positive for genes encoding leu-
kocidins (lukF and lukS as part of the hlg locus),
haemolysins (hl, hld, hlIII), aureolysin (aur), glutamyl
endopeptidase/V8-protease (sspA) and staphopain A
(sspP). The frequency of other genes was as follows:
leukocidin genes lukX in 40 and lukY in 36 (87.8%)
isolates, the haemolysin genes hlgA in 39 (95.1%),
and hla in 32 (78.0%) isolates, and the staphopain B
gene sspB in 39 (95.1%) isolates. The sak gene
encoding staphylokinase in combination with scn en-
coding a staphylococcal complement inhibitor was
detected in four (9.8%) isolates, chp (CHIPS) gene
coding for chemotaxis inhibitory protein in three
(7.3%) and the arcD-SCC gene coding for arginine/
ornithine antiporter in only a single (2.4%) isolate.
Twenty-nine (70.7%) isolates demonstrated highly
similar virulence gene proﬁles including the leukoci-
din genes (lukF, lukS, lukX, lukY), haemolysin genes
(hlgA, hl, hla, hld, hlIII), aureolysin gene (aur), gluta-
myl endopeptidase/V8-protease gene (sspA), stapho-
pain B gene (sspB), and staphopain A gene (sspP).
Other gene proﬁles were represented by one or two
isolates.
SplitsTree analysis was used for calculation of an
unrooted phylogenetic network depicting strain re-
latedness, using the data on presence/absence of genes
generated by DNA microarray. Except for one strain
of spa type t034, all isolates showed highly similar
gene patterns suggesting they were closely related (see
Fig. 1). Besides several minor clusters, one major
cluster comprised eight of the 14 MRSA ST398 iso-
lates from the south-east and two from the north of
Austria. Four isolates exhibited identical gene proﬁles
indicative of the same strain (Fig. 1). The analysis did
not result in a clear separation of isolates from the
two geographical regions but some time-dependent
genetic changes were evident as 9/10 isolates
recovered from 2004 to 2006 clustered very closely
together, while those from 2007 and 2008 showed
greater genetic variations, depicted in increased
distance in SplitsTree.
In accordance with previous studies, resistance to
tetracycline was almost universal among the isolates
and related to the presence of the tetM gene [3],
although two-thirds of the isolates also carried the
tetK gene. The ﬁnding of more than one tet gene
might be explained by the high antibiotic pressure
exerted by the widespread use of tetracycline in ani-
mal farming [5]. The absence of ermA or ermB en-
codingMLSB resistance in the isolates is in contrast to
the predominance of ermA in oxacillin-susceptible
S. aureus. It has been also suggested that ermB is
more common in staphylococci from animal sources
compared to human sources, but this could not be
conﬁrmed by our study [10]. The ﬁnding of a single
chloramphenicol-resistant isolate in this series
corroborates the reported rarity of the fexA gene in
MRSA ST398 [3].
Multi-resistance was found in 31.7% of isolates
and this rate may be considered low compared to
reports from other countries [3, 11]. However, the
absence of resistance to ciproﬂoxacin or trimetho-
prim/sulfamethoxazole among the isolates contrasts
with the reported resistance rates from Germany of
8% for ciproﬂoxacin and 4% for trimethoprim/
sulfamethoxazole [1, 3]. Overall, resistance gene pat-
terns were more homogeneous in isolates from south-
eastern Austria than those from northern Austria, as
some resistance genes (vga, aacA-aphA, fexA) were
only detected in strains from northern Austria.
As described previously, the tested MRSA ST398
isolates lacked genes encoding several clinically im-
portant S. aureus-associated virulence factors such as
PVL, toxic shock syndrome toxin, exfoliative toxins,
or enterotoxins [3, 8]. This is consistent with the fact
that clinical diseases in humans due to this genotype
are rarely observed [1]. While all isolates were positive
for lukS and lukF, no other leukocidin genes, such as
lukM, lukD, and lukE were present. Nevertheless, the
ﬁrst isolates of MRSA ST398 harbouring the PVL
gene have been described recently in the literature [12]
and there is therefore a need for continuous surveil-
lance as acquisition of this virulence trait could have a
signiﬁcant impact on the disease potential of the
genotype.
Notably the two MRSA ST398 isolates of spa type
t034 diﬀered particularly from others in the series as
one of these exhibited the highest number of virulence
genes and was susceptible to tetracycline, which is
rather uncommon in MRSA [3]. By contrast, the se-
cond t034 isolate had fewer virulence genes than all
other isolates and also lacked lukX and lukY. While
the lack of lukX in S. aureus, including MRSA, has
been described before [11], the absence of lukY has
not, to our knowledge, been reported. The second
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isolate was also the only representative from south-
eastern Austria to demonstrate resistance to tetra-
cycline and erythromycin-clindamycin. The Splits
Tree analysis showed that this strain clustered separ-
ately from the rest and epidemiological investigation
of animal contact and clinical background of the
patient did not provide an explanation for the orign of
this strain.
There are two main limitations of this study. First,
comparison of MRSA ST398 obtained from human
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major cluster
Fig. 1. [colour online]. SplitsTree visualizing the similarity among gene proﬁles obtained by DNA microarray analysis of 41
human isolates of MRSA ST398 in Austria (2004–2008). (a) Overview over the full SplitsTree depicting all 41 isolates. (b)
Detail zooming in on the region depicting the 40 highly similar MRSA ST398 isolates, while omitting atypical isolate LA-
MRSA_sA9. Among minor clusters, one major cluster containing almost exclusively strains isolated from the south of
Austria was found.
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and animal sources within the same time frame was
not possible, as screening of animals in Austria did
not begin before 2008 [5] ; second, the number of in-
cluded human samples is limited, due to the rarity of
this genotype in humans in Austria [2, 6].
To summarize, virulence and resistance gene pro-
ﬁles in Austrian MRSA ST398 appear at the moment
to be largely uniform, with only few variations be-
ginning in 2007. Our results support the hypothesis
that the MRSA ST398 isolates in Austria may have
originated from a single clone that was spread
throughout the country by animal trading [13]. Up to
now the input of new MRSA ST398 clones appears to
be a rare event. The data obtained facilitate world-
wide comparison of the virulence gene and anti-
microbial resistance properties of this genotype; due
to the already described occurrence of the PVL gene
in MRSA ST398 continuous surveillance is needed to
monitor a possible shift to a more virulent or more
resistant form.
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